
Company Number
00526209
Next Accounts
Aug 2025
Shareholders
pfizer luxco holdings sarl
Group Structure
View All
Industry
Other research and experimental development on natural sciences and engineering
+1Registered Address
pfizer limited, ramsgate road, sandwich, kent, CT13 9NJ
Website
http://www.pfizer.comPomanda estimates the enterprise value of PFIZER LIMITED at £2.1b based on a Turnover of £1.2b and 1.8x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of PFIZER LIMITED at £967.7m based on an EBITDA of £89m and a 10.87x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of PFIZER LIMITED at £1.4b based on Net Assets of £711.1m and 1.92x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Pfizer Limited is a live company located in kent, CT13 9NJ with a Companies House number of 00526209. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in November 1953, it's largest shareholder is pfizer luxco holdings sarl with a 100% stake. Pfizer Limited is a mature, mega sized company, Pomanda has estimated its turnover at £1.2b with high growth in recent years.
Pomanda's financial health check has awarded Pfizer Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 8 measures and has 1 areas for improvement. Company Health Check FAQs
8 Strong
2 Regular
1 Weak
Size
annual sales of £1.2b, make it larger than the average company (£14.3m)
£1.2b - Pfizer Limited
£14.3m - Industry AVG
Growth
3 year (CAGR) sales growth of 28%, show it is growing at a faster rate (5.4%)
28% - Pfizer Limited
5.4% - Industry AVG
Production
with a gross margin of 37%, this company has a comparable cost of product (37%)
37% - Pfizer Limited
37% - Industry AVG
Profitability
an operating margin of 6.5% make it more profitable than the average company (4.3%)
6.5% - Pfizer Limited
4.3% - Industry AVG
Employees
with 1244 employees, this is above the industry average (40)
1244 - Pfizer Limited
40 - Industry AVG
Pay Structure
on an average salary of £80.2k, the company has an equivalent pay structure (£69.9k)
£80.2k - Pfizer Limited
£69.9k - Industry AVG
Efficiency
resulting in sales per employee of £931k, this is more efficient (£395.4k)
£931k - Pfizer Limited
£395.4k - Industry AVG
Debtor Days
it gets paid by customers after 28 days, this is earlier than average (56 days)
28 days - Pfizer Limited
56 days - Industry AVG
Creditor Days
its suppliers are paid after 24 days, this is quicker than average (37 days)
24 days - Pfizer Limited
37 days - Industry AVG
Stock Days
it holds stock equivalent to 56 days, this is less than average (90 days)
56 days - Pfizer Limited
90 days - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Pfizer Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 45.3%, this is a lower level of debt than the average (50.5%)
45.3% - Pfizer Limited
50.5% - Industry AVG
Pfizer Limited's latest turnover from November 2023 is £1.2 billion and the company has net assets of £711.1 million. According to their latest financial statements, Pfizer Limited has 1,244 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | Nov 2015 | Nov 2014 | Nov 2013 | Nov 2012 | Nov 2011 | Nov 2010 | Nov 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 1,158,133,000 | 3,082,999,000 | 2,122,498,000 | 552,679,000 | 605,569,000 | 641,922,000 | 850,303,000 | 1,048,456,000 | 1,149,864,000 | 1,256,543,000 | 1,359,501,000 | 1,576,731,000 | 1,831,528,000 | 1,594,929,000 | 1,444,245,000 |
Other Income Or Grants | |||||||||||||||
Cost Of Sales | 1,117,917,000 | 1,383,080,000 | |||||||||||||
Gross Profit | 458,814,000 | 448,448,000 | |||||||||||||
Admin Expenses | 517,860,000 | 508,376,000 | |||||||||||||
Operating Profit | 75,740,000 | 128,922,000 | 93,858,000 | 92,162,000 | 30,838,000 | 19,042,000 | 217,737,000 | 202,078,000 | -87,801,000 | -70,048,000 | 9,316,000 | -59,046,000 | -59,928,000 | -46,263,000 | 5,122,000 |
Interest Payable | 453,000 | 371,000 | 31,000 | 428,000 | 84,000 | 170,000 | 253,000 | 864,000 | 1,314,000 | 1,367,000 | 1,244,000 | 3,051,000 | 100,050,000 | 104,019,000 | 86,464,000 |
Interest Receivable | 34,706,000 | 19,938,000 | 901,000 | 2,254,000 | 3,058,000 | 1,784,000 | 536,000 | 309,000 | 2,000 | 62,000 | 174,000 | 1,324,000 | 118,604,000 | 110,273,000 | 100,520,000 |
Pre-Tax Profit | 168,453,000 | 169,936,000 | 113,888,000 | 130,457,000 | 112,658,000 | 339,299,000 | 217,729,000 | 214,460,000 | -69,545,000 | 55,268,000 | 84,736,000 | 97,935,000 | -759,700,000 | 27,082,000 | 20,175,000 |
Tax | -35,409,000 | -33,486,000 | -95,964,000 | -15,244,000 | -14,083,000 | -96,668,000 | -40,711,000 | -42,392,000 | 2,234,000 | -15,197,000 | -2,536,000 | -5,408,000 | 184,769,000 | 20,975,000 | 22,434,000 |
Profit After Tax | 133,044,000 | 136,450,000 | 17,924,000 | 115,213,000 | 98,575,000 | 242,631,000 | 177,018,000 | 172,068,000 | -67,311,000 | 40,071,000 | 82,200,000 | 92,527,000 | -574,931,000 | 48,057,000 | 42,609,000 |
Dividends Paid | 550,000,000 | 190,000,000 | |||||||||||||
Retained Profit | 133,044,000 | -413,550,000 | 17,924,000 | 115,213,000 | 98,575,000 | 52,631,000 | 177,018,000 | 172,068,000 | -67,311,000 | 40,071,000 | 82,200,000 | 92,527,000 | -574,931,000 | 48,057,000 | 42,609,000 |
Employee Costs | 99,771,000 | 88,984,000 | 100,833,000 | 101,505,000 | 138,711,000 | 249,589,000 | 222,809,000 | 254,106,000 | 249,837,000 | 239,846,000 | 254,840,000 | 282,877,000 | 385,564,000 | 376,975,000 | 344,461,000 |
Number Of Employees | 1,244 | 1,175 | 1,212 | 1,258 | 1,365 | 2,253 | 2,257 | 2,222 | 2,189 | 2,216 | 2,357 | 3,280 | 4,134 | 4,512 | 4,337 |
EBITDA* | 89,013,000 | 139,884,000 | 104,860,000 | 103,733,000 | 42,963,000 | 41,983,000 | 238,745,000 | 231,751,000 | -67,530,000 | -44,727,000 | 34,946,000 | -17,655,000 | 28,689,000 | 40,524,000 | 98,264,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | Nov 2015 | Nov 2014 | Nov 2013 | Nov 2012 | Nov 2011 | Nov 2010 | Nov 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 42,864,000 | 45,309,000 | 48,149,000 | 48,090,000 | 51,814,000 | 53,027,000 | 85,933,000 | 89,309,000 | 89,632,000 | 89,629,000 | 88,330,000 | 71,103,000 | 103,117,000 | 790,244,000 | 832,912,000 |
Intangible Assets | 5,911,000 | 6,921,000 | 14,334,000 | 20,603,000 | 33,900,000 | 41,197,000 | 74,662,000 | 69,970,000 | 88,537,000 | 99,604,000 | 160,879,000 | 220,042,000 | 276,433,000 | 273,709,000 | 285,326,000 |
Investments & Other | 173,590,000 | 291,934,000 | 717,070,000 | 183,772,000 | 183,530,000 | 182,680,000 | 271,477,000 | 241,728,000 | 324,226,000 | 298,741,000 | 323,081,000 | 434,086,000 | 495,137,000 | 430,378,000 | 81,891,000 |
Debtors (Due After 1 year) | |||||||||||||||
Total Fixed Assets | 222,365,000 | 344,164,000 | 779,553,000 | 252,465,000 | 269,244,000 | 276,904,000 | 432,072,000 | 401,007,000 | 502,395,000 | 487,974,000 | 572,290,000 | 725,231,000 | 874,687,000 | 1,494,331,000 | 1,200,129,000 |
Stock & work in progress | 113,411,000 | 102,562,000 | 114,546,000 | 135,580,000 | 149,324,000 | 121,652,000 | 110,429,000 | 146,466,000 | 176,352,000 | 168,424,000 | 182,904,000 | 187,393,000 | 224,045,000 | 193,625,000 | 137,123,000 |
Trade Debtors | 91,157,000 | 630,743,000 | 323,150,000 | 94,180,000 | 235,851,000 | 286,692,000 | 285,742,000 | 290,130,000 | 279,011,000 | 313,303,000 | 294,611,000 | 273,771,000 | 361,605,000 | 334,414,000 | 260,562,000 |
Group Debtors | 837,501,000 | 1,278,815,000 | 1,339,018,000 | 1,137,881,000 | 944,964,000 | 860,554,000 | 1,010,922,000 | 933,395,000 | 782,168,000 | 659,405,000 | 679,038,000 | 550,895,000 | 2,975,995,000 | 3,024,521,000 | 1,672,323,000 |
Misc Debtors | 35,989,000 | 38,462,000 | 41,753,000 | 72,388,000 | 74,748,000 | 52,769,000 | 39,865,000 | 67,126,000 | 113,170,000 | 133,464,000 | 141,094,000 | 165,511,000 | 203,435,000 | 59,787,000 | 49,023,000 |
Cash | 193,000 | 236,000 | 2,000 | 205,000 | 14,467,000 | ||||||||||
misc current assets | 475,000 | 729,000 | 1,582,000 | ||||||||||||
total current assets | 1,078,058,000 | 2,050,582,000 | 1,818,467,000 | 1,440,029,000 | 1,404,887,000 | 1,322,142,000 | 1,447,687,000 | 1,438,699,000 | 1,350,701,000 | 1,274,789,000 | 1,297,883,000 | 1,177,572,000 | 3,765,285,000 | 3,612,347,000 | 2,133,498,000 |
total assets | 1,300,423,000 | 2,394,746,000 | 2,598,020,000 | 1,692,494,000 | 1,674,131,000 | 1,599,046,000 | 1,879,759,000 | 1,839,706,000 | 1,853,096,000 | 1,762,763,000 | 1,870,173,000 | 1,902,803,000 | 4,639,972,000 | 5,106,678,000 | 3,333,627,000 |
Bank overdraft | 8,000 | 11,000 | 44,000 | ||||||||||||
Bank loan | |||||||||||||||
Trade Creditors | 49,789,000 | 43,905,000 | 29,292,000 | 46,617,000 | 51,096,000 | 92,218,000 | 125,848,000 | 145,377,000 | 121,773,000 | 89,213,000 | 67,878,000 | 84,490,000 | 87,125,000 | 93,547,000 | 96,515,000 |
Group/Directors Accounts | 299,727,000 | 1,092,366,000 | 703,635,000 | 286,389,000 | 315,027,000 | 248,750,000 | 794,779,000 | 832,791,000 | 973,487,000 | 952,430,000 | 1,079,616,000 | 1,343,130,000 | 3,930,125,000 | 3,706,818,000 | 2,332,713,000 |
other short term finances | 1,162,000 | ||||||||||||||
hp & lease commitments | |||||||||||||||
other current liabilities | 194,353,000 | 550,954,000 | 383,276,000 | 283,260,000 | 176,386,000 | 219,313,000 | 145,691,000 | 188,398,000 | 128,492,000 | 111,518,000 | 125,266,000 | 131,269,000 | 257,733,000 | 248,358,000 | 207,359,000 |
total current liabilities | 543,877,000 | 1,687,225,000 | 1,116,203,000 | 616,266,000 | 542,509,000 | 560,292,000 | 1,066,318,000 | 1,166,610,000 | 1,223,752,000 | 1,153,161,000 | 1,272,760,000 | 1,558,889,000 | 4,274,983,000 | 4,049,885,000 | 2,636,587,000 |
loans | 167,153,000 | 198,108,000 | 136,465,000 | 40,212,000 | 37,820,000 | ||||||||||
hp & lease commitments | |||||||||||||||
Accruals and Deferred Income | 460,000 | 15,630,000 | 17,075,000 | 857,000 | 992,000 | 1,230,000 | 1,936,000 | 3,865,000 | 9,846,000 | 9,894,000 | |||||
other liabilities | |||||||||||||||
provisions | 21,652,000 | 27,372,000 | 115,416,000 | 21,189,000 | 185,352,000 | 186,377,000 | 24,969,000 | 91,653,000 | 81,035,000 | 1,800,000 | 13,722,000 | 21,061,000 | 41,771,000 | 113,772,000 | 148,576,000 |
total long term liabilities | 45,491,000 | 66,564,000 | 163,691,000 | 54,815,000 | 235,567,000 | 216,897,000 | 35,559,000 | 216,518,000 | 248,188,000 | 199,908,000 | 150,187,000 | 45,460,000 | 51,665,000 | 177,490,000 | 340,776,000 |
total liabilities | 589,368,000 | 1,753,789,000 | 1,279,894,000 | 671,081,000 | 778,076,000 | 777,189,000 | 1,101,877,000 | 1,383,128,000 | 1,471,940,000 | 1,353,069,000 | 1,422,947,000 | 1,604,349,000 | 4,326,648,000 | 4,227,375,000 | 2,977,363,000 |
net assets | 711,055,000 | 640,957,000 | 1,318,126,000 | 1,021,413,000 | 896,055,000 | 821,857,000 | 777,882,000 | 456,578,000 | 381,156,000 | 409,694,000 | 447,226,000 | 298,454,000 | 313,324,000 | 879,303,000 | 356,264,000 |
total shareholders funds | 711,055,000 | 640,957,000 | 1,318,126,000 | 1,021,413,000 | 896,055,000 | 821,857,000 | 777,882,000 | 456,578,000 | 381,156,000 | 409,694,000 | 447,226,000 | 298,454,000 | 313,324,000 | 879,303,000 | 356,264,000 |
Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 | Nov 2016 | Nov 2015 | Nov 2014 | Nov 2013 | Nov 2012 | Nov 2011 | Nov 2010 | Nov 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | 75,740,000 | 128,922,000 | 93,858,000 | 92,162,000 | 30,838,000 | 19,042,000 | 217,737,000 | 202,078,000 | -87,801,000 | -70,048,000 | 9,316,000 | -59,046,000 | -59,928,000 | -46,263,000 | 5,122,000 |
Depreciation | 4,297,000 | 4,693,000 | 4,733,000 | 4,274,000 | 4,828,000 | 11,282,000 | 9,904,000 | 11,106,000 | 9,204,000 | 9,690,000 | 10,800,000 | 12,682,000 | 66,938,000 | 65,628,000 | 71,954,000 |
Amortisation | 8,976,000 | 6,269,000 | 6,269,000 | 7,297,000 | 7,297,000 | 11,659,000 | 11,104,000 | 18,567,000 | 11,067,000 | 15,631,000 | 14,830,000 | 28,709,000 | 21,679,000 | 21,159,000 | 21,188,000 |
Tax | -35,409,000 | -33,486,000 | -95,964,000 | -15,244,000 | -14,083,000 | -96,668,000 | -40,711,000 | -42,392,000 | 2,234,000 | -15,197,000 | -2,536,000 | -5,408,000 | 184,769,000 | 20,975,000 | 22,434,000 |
Stock | 10,849,000 | -11,984,000 | -21,034,000 | -13,744,000 | 27,672,000 | 11,223,000 | -36,037,000 | -29,886,000 | 7,928,000 | -14,480,000 | -4,489,000 | -36,652,000 | 30,420,000 | 56,502,000 | 137,123,000 |
Debtors | -983,373,000 | 244,099,000 | 399,472,000 | 48,886,000 | 55,548,000 | -136,514,000 | 45,878,000 | 116,302,000 | 68,177,000 | -8,571,000 | 124,566,000 | -2,550,858,000 | 122,313,000 | 1,436,814,000 | 1,981,908,000 |
Creditors | 5,884,000 | 14,613,000 | -17,325,000 | -4,479,000 | -41,122,000 | -33,630,000 | -19,529,000 | 23,604,000 | 32,560,000 | 21,335,000 | -16,612,000 | -2,635,000 | -6,422,000 | -2,968,000 | 96,515,000 |
Accruals and Deferred Income | -371,771,000 | 166,233,000 | 116,234,000 | 106,739,000 | -43,165,000 | 72,916,000 | -44,636,000 | 63,771,000 | 16,974,000 | -13,748,000 | -15,849,000 | -126,512,000 | 19,269,000 | 40,999,000 | 207,359,000 |
Deferred Taxes & Provisions | -5,720,000 | -88,044,000 | 94,227,000 | -164,163,000 | -1,025,000 | 161,408,000 | -66,684,000 | 10,618,000 | 79,235,000 | -11,922,000 | -7,339,000 | -20,710,000 | -72,001,000 | -34,804,000 | 148,576,000 |
Cash flow from operations | 654,521,000 | -32,915,000 | -176,406,000 | -8,556,000 | -139,652,000 | 271,300,000 | 57,344,000 | 200,936,000 | -12,632,000 | -41,208,000 | -127,467,000 | 2,414,590,000 | 1,571,000 | -1,428,590,000 | -1,545,883,000 |
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | -118,344,000 | -425,136,000 | 533,298,000 | 242,000 | 850,000 | -88,797,000 | 29,749,000 | -82,498,000 | 25,485,000 | -24,340,000 | -111,005,000 | -61,051,000 | 64,759,000 | 348,487,000 | 81,891,000 |
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | |||||||||||||||
Group/Directors Accounts | -792,639,000 | 388,731,000 | 417,246,000 | -28,638,000 | 66,277,000 | -546,029,000 | -38,012,000 | -140,696,000 | 21,057,000 | -127,186,000 | -263,514,000 | -2,586,995,000 | 223,307,000 | 1,374,105,000 | 2,332,713,000 |
Other Short Term Loans | -1,162,000 | 1,162,000 | |||||||||||||
Long term loans | -167,153,000 | -30,955,000 | 61,643,000 | 136,465,000 | -40,212,000 | 2,392,000 | 37,820,000 | ||||||||
Hire Purchase and Lease Commitments | |||||||||||||||
other long term liabilities | |||||||||||||||
share issue | |||||||||||||||
interest | 34,253,000 | 19,567,000 | 870,000 | 1,826,000 | 2,974,000 | 1,614,000 | 283,000 | -555,000 | -1,312,000 | -1,305,000 | -1,070,000 | -1,727,000 | 18,554,000 | 6,254,000 | 14,056,000 |
cash flow from financing | -821,332,000 | 144,679,000 | 696,905,000 | -16,667,000 | 44,874,000 | -553,071,000 | 106,557,000 | -405,050,000 | 27,563,000 | -144,451,000 | -61,547,000 | -2,696,119,000 | 209,439,000 | 1,858,895,000 | 2,698,244,000 |
cash and cash equivalents | |||||||||||||||
cash | -193,000 | -43,000 | 234,000 | -203,000 | 205,000 | -14,467,000 | 14,467,000 | ||||||||
overdraft | 8,000 | -11,000 | 11,000 | -44,000 | 44,000 | ||||||||||
change in cash | -8,000 | 11,000 | -11,000 | 44,000 | -44,000 | -193,000 | -43,000 | 234,000 | -203,000 | 205,000 | -14,467,000 | 14,467,000 |
Perform a competitor analysis for pfizer limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other mega companies, companies in CT13 area or any other competitors across 12 key performance metrics.
PFIZER LIMITED group structure
Pfizer Limited has 10 subsidiary companies.
Ultimate parent company
PFIZER INC
#0003539
PFIZER LUXCO HOLDINGS SARL
#0101885
2 parents
PFIZER LIMITED
00526209
10 subsidiaries
Pfizer Limited currently has 6 directors. The longest serving directors include Dr Berkeley Phillips (Oct 2012) and Mr Edwin Pearson (Jan 2017).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Dr Berkeley Phillips | England | 55 years | Oct 2012 | - | Director |
Mr Edwin Pearson | England | 51 years | Jan 2017 | - | Director |
Mr Roger Smith | England | 58 years | Oct 2019 | - | Director |
Mr David Highton | England | 56 years | Jun 2022 | - | Director |
Mrs Sarah Sainsbury | 53 years | May 2024 | - | Director | |
Dr John McGinley | 48 years | Oct 2024 | - | Director |
P&L
November 2023turnover
1.2b
-62%
operating profit
75.7m
-41%
gross margin
37%
-1.37%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
November 2023net assets
711.1m
+0.11%
total assets
1.3b
-0.46%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
company number
00526209
Type
Private limited with Share Capital
industry
72190 - Other research and experimental development on natural sciences and engineering
46460 - Wholesale of pharmaceutical goods
incorporation date
November 1953
age
72
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
November 2023
previous names
N/A
accountant
-
auditor
KPMG LLP
address
pfizer limited, ramsgate road, sandwich, kent, CT13 9NJ
Bank
-
Legal Advisor
-
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to pfizer limited.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for PFIZER LIMITED. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|